Epigenetic Dysregulation in Follicular Lymphoma

References

• Swerdlow SH , CampoE , HarrisNLet al. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues (4th Edition) , IARC Press , Lyon, France ( 2008 ).
   Google Scholar
• Kridel R , SehnLH , GascoyneRD . Pathogenesis of follicular lymphoma . J. Clin. Invest.122 ( 10 ), 3424 – 3431 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y , GorhamJ , CossmanJ , JaffeE , CroceCM . The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining . Science229 ( 4720 ), 1390 – 1393 ( 1985 ).
   PubMed Web of Science ®Google Scholar
• Weiss LM , WarnkeRA , SklarJ , ClearyML . Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas . N. Engl. J. Med.317 ( 19 ), 1185 – 1189 ( 1987 ).
   PubMed Web of Science ®Google Scholar
• Roulland S , LebaillyP , LecluseY , HeutteN , NadelB , GauduchonP . Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals . Leukemia20 ( 1 ), 158 – 162 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Mcdonnell TJ , KorsmeyerSJ . Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18) . Nature349 ( 6306 ), 254 – 256 ( 1991 ).
   PubMed Web of Science ®Google Scholar
• Limpens J , StadR , VosCet al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals . Blood85 ( 9 ), 2528 – 2536 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Sungalee S , MamessierE , MorgadoEet al. Germinal center re-entries of BCL2-overexpressing B cells drive follicular lymphoma progression . J. Clin. Invest.124 ( 12 ), 5337 – 5351 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Basso K , Dalla-FaveraR . Germinal centres and B cell lymphoma genesis . Nat. Rev. Immunol.15 ( 3 ), 172 – 184 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Morin RD , Mendez-LagoM , MungallAJet al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma . Nature476 ( 7360 ), 298 – 303 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Pasqualucci L , Dominguez-SolaD , ChiarenzaAet al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma . Nature471 ( 7337 ), 189 – 195 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Okosun J , BodorC , WangJet al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma . Nat. Genet.46 ( 2 ), 176 – 181 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Green MR , GentlesAJ , NairRVet al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma . Blood121 ( 9 ), 1604 – 1611 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Green MR , KihiraS , LiuCLet al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation . Proc. Natl Acad. Sci. USA112 ( 10 ), E1116 – E1125 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Morin RD , JohnsonNA , SeversonTMet al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin . Nat. Genet.42 ( 2 ), 181 – 185 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bodor C , GrossmannV , PopovNet al. EZH2 mutations are frequent and represent an early event in follicular lymphoma . Blood122 ( 18 ), 3165 – 3168 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bodor C , O’RiainC , WrenchDet al. EZH2 Y641 mutations in follicular lymphoma . Leukemia25 ( 4 ), 726 – 729 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ryan RJ , NittaM , BorgerDet al. EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas . PLoS ONE6 ( 12 ), e28585 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Pasqualucci L , KhiabanianH , FangazioMet al. Genetics of follicular lymphoma transformation . Cell Rep.6 ( 1 ), 130 – 140 ( 2014 )
   PubMed Web of Science ®Google Scholar
• Yap DB , ChuJ , BergTet al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation . Blood117 ( 8 ), 2451 – 2459 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Sneeringer CJ , ScottMP , KuntzKWet al. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas . Proc. Natl Acad. Sci. USA107 ( 49 ), 20980 – 20985 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Li H , KaminskiMS , LiYet al. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma . Blood123 ( 10 ), 1487 – 1498 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Shen H , LairdPW . Interplay between the cancer genome and epigenome . Cell153 ( 1 ), 38 – 55 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Plass C , PfisterSM , LindrothAM , BogatyrovaO , ClausR , LichterP . Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer . Nat. Rev. Genet.14 ( 11 ), 765 – 780 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bannister AJ , KouzaridesT . Regulation of chromatin by histone modifications . Cell Res.21 ( 3 ), 381 – 395 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Pasqualucci L , TrifonovV , FabbriGet al. Analysis of the coding genome of diffuse large B-cell lymphoma . Nat. Genet.43 ( 9 ), 830 – 837 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Green MR , AlizadehAA . Common progenitor cells in mature B-cell malignancies: implications for therapy . Curr. Opin. Hematol.21 ( 4 ), 333 – 340 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Pastore A , JurinovicV , KridelRet al. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry . Lancet Oncol.16 ( 9 ), 1111 – 1122 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Okosun J , PackhamG , FitzgibbonJ . Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies . Expert Opin. Investig. Drugs23 ( 10 ), 1321 – 1332 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Esteller M . Epigenetics in cancer . N. Engl. J. Med.358 ( 11 ), 1148 – 1159 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Jiang Y , MelnickA . The epigenetic basis of diffuse large B-cell lymphoma . Semin. Hematol.52 ( 2 ), 86 – 96 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bernstein BE , MikkelsenTS , XieXet al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells . Cell125 ( 2 ), 315 – 326 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Gan Q , YoshidaT , McdonaldOG , OwensGK . Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells . Stem Cells25 ( 1 ), 2 – 9 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Van Galen JC , DukersDF , GirothCet al. Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction . Eur. J. Immunol.34 ( 7 ), 1870 – 1881 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Velichutina I , ShaknovichR , GengHet al. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphoma genesis . Blood116 ( 24 ), 5247 – 5255 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Caganova M , CarrisiC , VaranoGet al. Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphoma genesis . J. Clin. Invest.123 ( 12 ), 5009 – 5022 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Beguelin W , PopovicR , TeaterMet al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation . Cancer Cell23 ( 5 ), 677 – 692 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Berg T , ThoeneS , YapDet al. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphoma genesis . Blood123 ( 25 ), 3914 – 3924 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mccabe MT , OttHM , GanjiGet al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations . Nature492 ( 7427 ), 108 – 112 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Knutson SK , WigleTJ , WarholicNMet al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells . Nat. Chem. Biol.8 ( 11 ), 890 – 896 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bitler BG , AirdKM , GaripovAet al. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers . Nat. Med.21 ( 3 ), 231 – 238 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Fillmore CM , XuC , DesaiPTet al. EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors . Nature520 ( 7546 ), 239 – 242 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Knutson SK , WarholicNM , WigleTJet al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2 . Proc. Natl Acad. Sci. USA110 ( 19 ), 7922 – 7927 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Clinical Trial Database: NCT02395601 . www.clinicaltrials.gov/ct2/show/NCT02395601
   Google Scholar
• Clinical Trial Database: NCT01897571 . www.clinicaltrials.gov/ct2/show/NCT01897571
   Google Scholar
• Clinical Trial Database: NCT02082977 . www.clinicaltrials.gov/ct2/show/NCT02082977
   Google Scholar
• Ribrag V , SoriaJ , ReydermanLet al. Phase 1 study of E7438 (EPZ-6438), an enhancer of zeste homolog 2 (EZH2) inhibitor: dose determination and preliminary activity in non-hodgkin lymphoma . Presented at : 13th International Conference on Malignant Lymphoma.Lugano, Switzerland , 17 – 20 June , 2015 .
   Google Scholar
• Rao RC , DouY . Hijacked in cancer: the KMT2 (MLL) family of methyltransferases . Nat. Rev. Cancer15 ( 6 ), 334 – 346 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lee JE , WangC , XuSet al. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation . eLife2 , e01503 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Guo C , ChenLH , HuangYet al. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation . Oncotarget4 ( 11 ), 2144 – 2153 ( 2013 ).
   PubMedGoogle Scholar
• Ng SB , BighamAW , BuckinghamKJet al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome . Nat. Genet.42 ( 9 ), 790 – 793 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Oike Y , TakakuraN , HataAet al. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis . Blood93 ( 9 ), 2771 – 2779 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Yao TP , OhSP , FuchsMet al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300 . Cell93 ( 3 ), 361 – 372 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Fenaux P , MuftiGJ , Hellstrom-LindbergEet al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, Phase III study . Lancet Oncol.10 ( 3 ), 223 – 232 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kantarjian HM , ThomasXG , DmoszynskaAet al. Multicenter, randomized, open-label, Phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia . J. Clin. Oncol.30 ( 21 ), 2670 – 2677 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Alhejaily A , DayAG , FeilotterHE , BaetzT , LebrunDP . Inactivation of the CDKN2A tumor-suppressor gene by deletion or methylation is common at diagnosis in follicular lymphoma and associated with poor clinical outcome . Clin. Cancer Res.20 ( 6 ), 1676 – 1686 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Giachelia M , BozzoliV , D’AlòFet al. Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker . J. Mol. Diagn.16 ( 4 ), 467 – 476 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• O’Riain C , O’SheaDM , YangYet al. Array-based DNA methylation profiling in follicular lymphoma . Leukemia23 ( 10 ), 1858 – 1866 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Loeffler M , KreuzM , HaakeAet al. Genomic and epigenomic co-evolution in follicular lymphomas . Leukemia29 ( 2 ), 456 – 463 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• De S , ShaknovichR , RiesterMet al. Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity . PLoS Genet.9 ( 1 ), e1003137 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Clozel T , YangS , ElstromRLet al. Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma . Cancer Discov.3 ( 9 ), 1002 – 1019 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Huang FW , HodisE , XuMJ , KryukovGV , ChinL , GarrawayLA . Highly recurrent TERT promoter mutations in human melanoma . Science339 ( 6122 ), 957 – 959 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Horn S , FiglA , RachakondaPSet al. TERT promoter mutations in familial and sporadic melanoma . Science339 ( 6122 ), 959 – 961 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fredriksson NJ , NyL , NilssonJA , LarssonE . Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types . Nat. Genet.46 ( 12 ), 1258 – 1263 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mathelier A , LefebvreC , ZhangAWet al. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas . Genome Biol.16 , 84 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Koues OI , KowalewskiRA , ChangLWet al. Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma . Immunity42 ( 1 ), 186 – 198 ( 2015 ).
   PubMed Web of Science ®Google Scholar